ScholarIQanswers from OpenAlex & ORCID
André Robidoux
ResearcherPublications, citations & collaboration network
André Robidoux is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does André Robidoux have?
ScholarIQindexed works
André Robidoux has 131 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does André Robidoux have?
ScholarIQcitation count
André Robidoux has 21,664 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of André Robidoux?
ScholarIQh-index
André Robidoux has an h-index of 44 in OpenAlex.
What is the i10-index of André Robidoux?
ScholarIQi10-index
André Robidoux has an i10-index of 79 in OpenAlex.
What is the OpenAlex record for André Robidoux?
ScholarIQopenalex
The OpenAlex for André Robidoux is on the source record.
What are the most-cited papers on André Robidoux?
ScholarIQmost cited works
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
Bernard Fisher, Joseph P. Costantino, D. Lawrence Wickerham, Carol Redmond, Maureen Kavanah, Walter M. Cronin, Victor G. Vogel, André Robidoux, Nikolay Dimitrov, James N. Atkins, Mary B. Daly, Samuel Wieand, Elizabeth Tan-Chiu, Leslie G. Ford, Norman Wolmark, other National Surgical Adjuvant Breast, Bowel Project Investigators
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
David N. Krag, Stewart Anderson, Thomas B. Julian, Ann Brown, Seth P. Harlow, Joseph P. Costantino, Takamaru Ashikaga, Donald L. Weaver, Eleftherios P. Mamounas, Lynne M Jalovec, Thomas G. Frazier, R. Dirk Noyes, André Robidoux, Hugh MC Scarth, Norman Wolmark
Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial
David N. Krag, Stewart Anderson, Thomas B. Julian, Ann Brown, Seth P. Harlow, Takamaru Ashikaga, Donald L. Weaver, Bárbara Miller, Lynne M Jalovec, Thomas G. Frazier, R. Dirk Noyes, André Robidoux, Hugh MC Scarth, Denise Mammolito, David R. McCready, Eleftherios P. Mamounas, Joseph P. Costantino, Norman Wolmark